| December 8-15, 2014|
Video of the Week ...
Not your standard grocery store Christmas music (2:15)
... to Rafi Ahmed, Eric Hunter, and Bali Pulendran on being 50% of the total number of Emoryites named in Reuter's "The World's Most Influential Scientific Minds, 2014;" a distinction that is earned by having published the greatest number of papers that rank in the top 1% for citations in their field and year of publication. (The other three were Dana Barr, Leslee Shaw, and Peter Wilson)
"The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!' but 'That's funny...'
In other news...
- Isaac Asimov (1920- 1992)
Jane Lawson (December 15) and Monica Trigg (December 15)
Life should not only be lived, it should be celebrated.
We celebrate YOU!!
One of the toughest of the grand challenges facing HIV is the fact that CD4+ T-cells can be latently infected for years; effectively hiding in plain sight from antiretroviral SWAT teams. So it is particularly good news that Paul Johnson recently received new "Phase II" funding from the Gates Foundation Grand Challenges Exploration (GCE) mechanism, in recognition of the fact that he has made significant progress in his "Single cell transcriptional profiling of latently infected CD4+ T cells" idea since it was funded with a Phase I GCE grant in 2011.
As Paul says: "By analyzing expression of a panel of molecules that are differentially expressed on the surface of CD4+ T cells, we will identify novel cell surface biomarkers that, either alone or in combination, represent a distinct signature of latently infected cells. The use of single cell transcriptional profiling represents a unique approach to address the fundamental challenges in characterizing latently infected reservoirs and should provide essential information necessary for the development of strategies for viral eradication."
Read More About It.
Kim Workwoski has received new funding from AbbVie for “A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Coadministration of ABT-493 and ABT-530 With and Without RBV in Subjects with Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection.”
Nurse Practitioner Sought:
Aid Gwinnett has a full time position available for a Nurse Practitioner to provide adult ambulatory care in their Ric Crawford Clinic.
• Direct resumes to Clinic Coordinator Patricia Kohler, NP at email@example.com (678.990.6422)
Faculty and Postdoc Students Sought: Biostatistics for Translational Research Course
Registration is open to faculty and postdocs and tuition may be covered by Emory courtesy scholarship for those who are eligible. The course introduces statistical concepts and analytical methods, and emphasizes basic concepts of study design (including clinical trials) and inferential methods in order to analyze biomedical and public health data. Prerequisite: college algebra and certificate program permission.
• Information: Contact Cheryl Sroka
The CDC has released its released its 2014 HIV Vital Signs, which includes a Morbidity and Mortality Weekly Report (MMWR) -- Vital Signs: HIV Diagnosis, Care, and Treatment Among Persons Living with HIV — United States, 2011 -- and an accompanying fact sheet, HIV Care Saves Lives, Viral Suppression is Key.
The good news: According to the report 86% of the 1.2M people with HIV in the US knew their status. The less good news: < half (40%) were in HIV medical care. The bad news: < a third (30%) had achieved viral suppression and, in addition, almost half (49%) of young people aged 18-24 living with HIV did not know they had the virus, and < a fifth (13%) of those aged 18-24 had achieved viral suppression compared with > a third (37%) of those over 65 years of age.
No State news this week
All NIH applications due on or after 01/25/15 are required to use a new Biosketch format. See the "Focus" section below for more details.
The New NIH Biosketch Format
For those of us of a certain age it seems like the information requested on an NIH biosketch has surged in stages over time, like waves of an incoming tide.
Well, the moon is full and the tide is higher than it's ever been before.
CLIFF NOTES VERSION:
Effective for NIH applications due on or after 01/25/15, the NIH is implementing an expanded biosketch format that has been designed to explicitly lay out your capabilities and accomplishments for the reviewers, instead of asking them to just infer those from your publication list.
As described in NOT-OD-15-024 and in this sample completed biosketch, the new format is summarized below:
- Page limit extended from 4 pages to 5 pages;
- Personal Statement remains as Section A (see sample biosketch for additional guidance on the Personal Statement);
- Positions & Honors sections remains as Section B;
- Section C is now “Contributions to Science" (this section allows you to describe up to five of your most significant contributions to science, may include the historical background that framed your research, and may outline the central findings of your prior work and the influence of those findings on your field. Each description can be accompanied by a listing of up to four relevant peer-reviewed publications or other non-publication research products (see sample biosketch for full list of possible research products which may be included). In addition to the descriptions, you may also include a link to a full list of you published work as found in a publicly available digital database such as MyBibliography or SciENcv);
- Research Support remains as Section D.
As Sally Rockey said in the 5/22/14 edition of Rock Talk: "The primary focus of the new NIH biosketch will be the magnitude and significance of the scientific advances associated with a researcher’s discoveries and the specific role the researcher played in those findings. This change will help reviewers evaluate you not by where you’ve published or how many times, but instead by what you’ve accomplished."
THE GOVERNMENT IS HERE TO HELP:
To make the mechanics of this less traumatic there is an online interface -- Science Experts CV (SciENcv) -- that will be very useful in creating, adapting (for each new application), and updating your new biosketch.
DO THESE THINGS OVER THE HOLIDAYS:
• Read the Notice (NOT-OD-15-024)
• Watch a YouTube Video about how to use SciENcv to manage your biosketch
• Download the new forms and instructions
• Download the sample completed biosketch
• Start drafting YOUR new Section C.